European Union - English - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastic agents - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Israel - English - Ministry of Health

sanofi israel ltd - duvelisib - capsules - duvelisib - 15 mg - lurbinectedin - copiktra is a kinase inhibitor indicated for the treatment of adult patients with:• relapsed or refractory chronic lymphocytic leukemia (cll) or small lymphocytic lymphoma (sll) after at least two prior therapies.• relapsed or refractory follicular lymphoma (fl) after at least two prior systemic therapies.

Israel - English - Ministry of Health

sanofi israel ltd - duvelisib - capsules - duvelisib - 25 mg - lurbinectedin - copiktra is a kinase inhibitor indicated for the treatment of adult patients with:• relapsed or refractory chronic lymphocytic leukemia (cll) or small lymphocytic lymphoma (sll) after at least two prior therapies.• relapsed or refractory follicular lymphoma (fl) after at least two prior systemic therapies.